Thursday 10th March 2016
|Text too small?|
Trilogy International, the skincare and home fragrance company, raised its guidance for full-year sales and earnings, partly on the contribution from New Zealand cosmetics and fragrance distribution business, CS Company, acquired last August.
Revenue in the 12 months ending March 31 is forecast to exceed $83 million, up from the $75 million-to-$79 million range given at the time of the first-half results and more than double the year-earlier period.
Earnings before interest and tax are expected to exceed $14 million, the top end of its previous guidance and profit before tax is forecast to top $13 million, compared to a previous guidance range of $10 million to $12 million.
Trilogy last year agreed to buy privately held CS Company, New Zealand's largest independent importer and distributor of fragrances, cosmetics and toiletries, for $37 million plus any earn-out payments. The purchase was debt funded. It added to assets including the Trilogy, Ecoya and Goodness brands.
Trilogy shares rose 2.2 percent to $3.30 and have soared 302 percent in the past 12 months.
The company plans to release its full-year results in May and give guidance for the 2017 year.
No comments yet
NZ dollar falls with Aussie after Westpac's RBA rate cut call
Intuit juggernaut grows QuickBooks subscribers but momentum slows
Reaction to Budget rules relaxation shows balance 'about right', says Ardern
Augusta lifts net profit six fold as investors flock into new funds
Annual exports to China top $15 billion for first time
Gentrack posts $8.7M loss on CA Plus write-down
Westpac says RBNZ capital proposals would add $6,000 p.a. to an Auckland mortgage
Cavalier says market conditions still challenging
Ryman hikes dividend as annual earnings grow on wider development margin
24th May 2019 Morning Report